LGND — Ligand Pharmaceuticals Incorporated stock price, charts and financials

QT81Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
295.70
+2.55+0.87%
OverviewShort InterestFilings
LGNDQT81Ligand Pharmaceuticals Incorporated·NASDAQ
295.70+0.87%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Aug 04, 20264Statement of changes in beneficial ownership
Jul 22, 2026S-8Registration of employee benefit securities
Jul 14, 20268-KCurrent report
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 25, 20268-KCurrent report
Jun 22, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20268-KCurrent report
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 18, 20268-KCurrent report
May 18, 2026DEFA14AAdditional proxy soliciting materials
#1 / 25 of 433
Page
▼
/ 18